Cellectis (CLLS) Tops Q4 EPS by 58c

Cellectis (NASDAQ: CLLS) reported Q4 EPS of ($0.02), $0.58 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $17.32 million versus the consensus estimate of $18.58 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• H.B. Fuller makes £715M cash offer to acquire Advanced Medical Solutions
• NRC Health (NRC) Reiterated at Market Outperform by Citizens Ahead of Annual Forum